Windlas Biotech share news, announcements and annual reports
NSE: WINDLASBSE: 543329Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 28 Oct 2026. Previous close ₹877.40.
28 Oct: open ₹883.30, high ₹899.00, low ₹873.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,834 Cr1,237th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 27.61
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed. Price to book: how it is worked out
- 3.16
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.71%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 12.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed.
- 0.05
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 38,60045.6% delivered
Windlas Biotech has 322 announcements on record, routine notices left out; 2 in the 30 days to 29 Oct 2026, the latest on 12 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Windlas Biotech quarterly results
The board met on 10 Aug 2026 to consider financial results
Notice filed 4 Aug 2026
To consider and approve the financial results for the period ended Jun 30, 2026
Windlas Biotech annual reports, presentations and earnings calls
The company's own documents, latest first.Windlas Biotech financials, year by year
Annual reports5
- Annual report, year to Mar 20261 Jul 2026
- Annual report, year to Mar 20255 Jul 2025
- Annual report, year to Mar 202429 Aug 2024
- Annual report, year to Mar 202318 Aug 2023, a zip file
- Annual report, year to Mar 202226 Aug 2022, a zip file
Investor presentations21
- Investor Presentation10 Aug 2026
- Investor Presentation21 May 2026
- Investor Presentation5 Feb 2026
- Investor Presentation6 Nov 2025
- Investor Presentation12 Aug 2025
16 earlier presentations
- Investor Presentation22 May 2025
- Investor Presentation11 Feb 2025
- Investor Presentation12 Nov 2024
- Investor Presentation13 Aug 2024
- Investor Presentation20 May 2024
- Investor Presentation8 Feb 2024
- Investor Presentation8 Nov 2023
- Investor Presentation5 May 2023
- Investor Presentation8 Feb 2023
- Investor Presentation8 Nov 2022
- Investor Presentation for Q1 (FY23) Financial Results.4 Aug 2022
- Investor Presentation12 May 2022
- Investor Presentation2 Feb 2022
- Investor Presentation1 Nov 2021
- Investor Presentation9 Sep 2021
- Investor Presentation8 Sep 2021
Earnings calls38
- Earnings call transcript of Q1 FY2714 Aug 2026
- Link of Recording11 Aug 2026
- Transcript28 May 2026
- Link of Recording22 May 2026
- Transcript11 Feb 2026
33 earlier call documents
- Link of Recording6 Feb 2026
- Transcript11 Nov 2025
- Link of Recording7 Nov 2025
- Transcript21 Aug 2025
- Link of Recording13 Aug 2025
- Transcript29 May 2025
- Link of Recording23 May 2025
- Transcript18 Feb 2025
- Link of Recording12 Feb 2025
- Transcript21 Nov 2024
- Link of Recording13 Nov 2024
- Transcript20 Aug 2024
- Link of Recording14 Aug 2024
- Transcript27 May 2024
- Link of Recording21 May 2024
- Transcript16 Feb 2024
- Link of Recording9 Feb 2024
- Transcript17 Nov 2023
- Link of Recording9 Nov 2023
- Transcript16 Aug 2023
- Link of Recording9 Aug 2023
- Transcript11 May 2023
- Link of Recording8 May 2023
- Transcript14 Feb 2023
- Link of Recording9 Feb 2023
- Transcript of Analysts/Institutional Investor Meet/Con. Call14 Nov 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call9 Nov 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call9 Aug 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call5 Aug 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call16 May 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call12 May 2022
- Transcript14 Feb 2022
- Transcript9 Nov 2021
Windlas Biotech share news and announcements
Newest first. Page 1 of 7.
Oct 2026
12 Oct · Management
12 Oct · Management
Sep 2026
1 Sep · Analysts
Aug 2026
10 Aug · Results
5 Aug · Analysts
5 Aug · Analysts
4 Aug · Board meeting
Jul 2026
9 Jul · Analysts
2 Jul · General Updates
1 Jul · General Updates
1 Jul · Meeting
1 Jul · Corporate action
Jun 2026
29 Jun · Rating
26 Jun · Analysts
24 Jun · Analysts
24 Jun · Analysts
May 2026
18 May · General Updates
18 May · Analysts
18 May · Closure of Buy Back
5 May · Board meeting
Apr 2026
27 Apr · Buyback
17 Apr · Board meeting
15 Apr · Analysts
14 Apr · Board meeting
Mar 2026
13 Mar · Disclosure
Feb 2026
16 Feb · Meeting
16 Feb · Meeting
13 Feb · Analysts
13 Feb · Analysts
5 Feb · Management
5 Feb
5 Feb · Results
Jan 2026
29 Jan · Analysts
28 Jan · Board meeting
22 Jan · Analysts
Dec 2025
29 Dec · Analysts
29 Dec · Analysts
24 Dec · Analysts
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 13 Oct 2026Board or managers changeddown 1.47%−2.7 pts vs Nifty 500market median 0.0% · five sessions −4.5% (−5.5 pts vs Nifty 500) · volume 0.9× usual · delivery −14.3 pts against usual · The announcement
- 11 Aug 2026Resultsup 12.32%+12.6 pts vs Nifty 500market median −0.7% · five sessions +11.2% (+11.9 pts vs Nifty 500) · volume 55.4× usual · delivery −44.7 pts against usual · The announcement
- 30 Jun 2026Credit ratingup 0.05%+0.1 pts vs Nifty 500market median 0.0% · five sessions −0.1% (−2.0 pts vs Nifty 500) · volume 1.1× usual · delivery +5.5 pts against usual · The announcement
- 22 May 2026Resultsup 0.97%+0.8 pts vs Nifty 500market median −0.7% · five sessions +6.5% (+6.2 pts vs Nifty 500) · volume 4.6× usual · delivery +6.1 pts against usual · The announcement
- 19 May 2026Buybackdown 1.13%−1.4 pts vs Nifty 500market median 0.0% · five sessions +1.2% (−0.9 pts vs Nifty 500) · volume 0.8× usual · delivery +4.6 pts against usual · The announcement
- 28 Apr 2026Buybackdown 1.38%−1.1 pts vs Nifty 500market median 0.0% · five sessions +0.8% (+0.8 pts vs Nifty 500) · volume 0.4× usual · delivery −3.8 pts against usual · The announcement
- 6 Feb 2026Resultsup 2.05%+2.0 pts vs Nifty 500market median −0.7% · five sessions −4.7% (−5.7 pts vs Nifty 500) · volume 2.0× usual · delivery −5.3 pts against usual · The announcement
- 7 Nov 2025Resultsdown 5.74%−5.8 pts vs Nifty 500market median −0.7% · five sessions −10.0% (−11.2 pts vs Nifty 500) · volume 9.2× usual · delivery +14.1 pts against usual · The announcement
- 12 Aug 2025Resultsup 0.79%+1.1 pts vs Nifty 500market median −0.7% · five sessions +12.2% (+10.2 pts vs Nifty 500) · volume 1.6× usual · delivery −3.4 pts against usual · The announcement
- 23 May 2025Resultsdown 5.52%−6.3 pts vs Nifty 500market median −0.7% · five sessions −3.2% (−4.4 pts vs Nifty 500) · volume 8.4× usual · delivery −3.0 pts against usual · The announcement
17 earlier announcements
- 8 Apr 2025Credit ratingdown 0.63%−2.5 pts vs Nifty 500market median 0.0% · five sessions +14.7% (+8.3 pts vs Nifty 500) · volume 0.6× usual · delivery −1.8 pts against usual · The announcement
- 12 Nov 2024Resultsdown 3.45%−2.3 pts vs Nifty 500market median −0.7% · five sessions −6.4% (−3.8 pts vs Nifty 500) · volume 1.9× usual · delivery −13.1 pts against usual · The announcement
- 13 Aug 2024Resultsdown 11.99%−11.1 pts vs Nifty 500market median −0.7% · five sessions −9.5% (−11.0 pts vs Nifty 500) · volume 4.9× usual · delivery −9.7 pts against usual · The announcement
- 21 May 2024Resultsup 9.92%+9.7 pts vs Nifty 500market median −0.7% · five sessions +12.6% (+11.0 pts vs Nifty 500) · volume 17.1× usual · delivery −18.4 pts against usual · The announcement
- 21 May 2024Board or managers changedup 9.92%+9.7 pts vs Nifty 500market median 0.0% · five sessions +12.6% (+11.0 pts vs Nifty 500) · volume 17.1× usual · delivery −18.4 pts against usual · The announcement
- 8 Feb 2024Resultsup 8.85%+9.5 pts vs Nifty 500market median −0.7% · five sessions +4.6% (+5.5 pts vs Nifty 500) · volume 11.0× usual · delivery −25.9 pts against usual · The announcement
- 8 Nov 2023Resultsup 2.21%+1.8 pts vs Nifty 500market median −0.7% · five sessions +11.6% (+10.9 pts vs Nifty 500) · volume 1.9× usual · delivery −15.5 pts against usual · The announcement
- 8 May 2023Dividendup 3.31%+2.3 pts vs Nifty 500market median 0.0% · five sessions +4.9% (+3.6 pts vs Nifty 500) · volume 5.1× usual · delivery −5.7 pts against usual · The announcement
- 5 May 2023Buybackup 0.10%+0.9 pts vs Nifty 500market median 0.0% · five sessions +6.4% (+5.9 pts vs Nifty 500) · volume 1.1× usual · delivery −4.8 pts against usual · The announcement
- 4 May 2023Buybackup 0.87%0.0 pts vs Nifty 500market median 0.0% · five sessions +7.5% (+6.3 pts vs Nifty 500) · volume 0.9× usual · delivery −15.0 pts against usual · The announcement
- 6 Dec 2022Buybackdown 1.50%−1.2 pts vs Nifty 500market median 0.0% · five sessions −2.4% (−1.5 pts vs Nifty 500) · volume 0.4× usual · delivery +3.2 pts against usual · The announcement
- 10 Nov 2022Buybackdown 3.04%−2.2 pts vs Nifty 500market median 0.0% · five sessions −5.1% (−5.7 pts vs Nifty 500) · volume 0.7× usual · delivery +8.5 pts against usual · The announcement
- 4 Aug 2022Resultsdown 1.05%−1.1 pts vs Nifty 500market median −0.7% · five sessions −5.2% (−6.6 pts vs Nifty 500) · volume 7.9× usual · delivery −23.1 pts against usual · The announcement
- 13 May 2022Resultsup 5.38%+5.3 pts vs Nifty 500market median −0.7% · five sessions +4.3% (+3.7 pts vs Nifty 500) · volume 2.3× usual · delivery −12.5 pts against usual · The announcement
- 13 May 2022Dividendup 5.38%+5.3 pts vs Nifty 500market median 0.0% · five sessions +4.3% (+3.7 pts vs Nifty 500) · volume 2.3× usual · delivery −12.5 pts against usual · The announcement
- 24 Sep 2021Credit ratingdown 0.99%−0.9 pts vs Nifty 500market median 0.0% · five sessions −4.8% (−3.8 pts vs Nifty 500) · volume 0.5× usual · delivery +16.1 pts against usual · The announcement
- 8 Sep 2021Resultsdown 0.33%−0.5 pts vs Nifty 500market median −0.7% · five sessions −2.7% (−4.3 pts vs Nifty 500) · delivery −4.6 pts against usual · The announcement
Windlas Biotech results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.